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Introduction & Objectives
• Proximal and distal pancreatic tumors have different
anatomic location (head/tail of pancreas) and molecular
biology.
• Patients with distal tumors (body/tail) have been associated
with delayed diagnosis and poorer survival given the
anatomic location.
• Understanding the anatomic and genetic differences in
survival can add further knowledge on prognostic outcomes
and therapeutic management for future patients.

Research Question
& Hypothesis
• Research Question
• In adult patients with pancreatic cancer, how does the
tumor location at the proximal pancreas compared to the
distal pancreas affect survival when diagnosed at the same
stage?
• Hypothesis
• In adult patients with pancreatic cancer, anatomic tumor
location would contribute to poorer survival in distal
tumors compared to head tumors when diagnosed at the
same stage.

Methods
• Retrospective medical chart review on Epic patient
database at Thomas Jefferson University Hospital
• 907 patient screened, 324 reviewed patients with
pancreatic adenocarcinoma (236 head and 88 body/tail)
diagnosed from 2011-2017
• Inclusion criteria: 18 years or older, biopsy proven
adenocarcinoma and a single mass in the pancreas at
presentation.

Data Analysis
• Data mining and entry was performed using REDcap
software.
• CDC National Death Index Registry and obituary reports
were utilized to determine official dates of death.
• Comparison of median survival from onset of diagnosis in
cancer staging and tumor location
• Comparative statistics when corrected for stage and
surgery (hazard ratio, confidence intervals, p-values, etc.)

Results

Results

Results
•

The overall body/tail cancer survival was significantly less than pancreatic
head cancer (11.2 months body/tail compared to 16 months head,
p=0.015).

•

When broken down by stage at diagnosis, the survival for body/tail cases
was not statistically significant to pancreatic head cases (Stage I/II,
head=21 months, body/tail=25.7 months, p=0.436; Stage III, head=11.7
months, body/tail=18.0 months, p=0.393; Stage IV, head=6.5 months,
body/tail=4.9 months, p=0.675).

•

When broken down by surgery, the survival for body/tail cases was not
statistically significant in comparison to pancreatic head cases (surgery,
head=24.6 months, body/tail=19.4 months, p=0.795; no surgery, head=8.5
months, body/tail=5.5 months, p=0.349).

•

After adjusting for both stage and surgery, the hazard ratio of body/tail
reduced from 1.42 to 0.96.

Conclusions
• When stratified by stage there was no statistically significant
difference in median survival between the proximal or distal
groups.
• When stratified by surgical resection there was also no
statistically significant difference in median survival between
the proximal or distal groups.
• In the early-stage distal pancreatic adenocarcinoma group
there was a trend towards improved survival of distal over the
proximal group, though this was not statistically significant.
However, low overall numbers of distal pancreatic cancer
cases may have contributed to the non-statistically significant
value.

Future Directions
• Given the trend towards higher median survival in the
early-stage distal group, we plan to acquire data from
2017 to present to increase the number of distal tumors in
the study population.
• We plan to perform a retrospective review
Next-Generation Sequencing on tumor tissues to assess for
differences in molecular characteristics between proximal
versus distal tumors.
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